Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation

Marios Dimitriou, Teresa Mortera-Blanco, Magnus Tobiasson, Stefania Mazzi, Madeleine Lehander, Kari Högstrand, Mohsen Karimi, Gunilla Walldin, Monika Jansson, Sofie Vonlanthen, Per Ljungman, Saskia Langemeijer, Tetsuichi Yoshizato, Eva Hellström-Lindberg, Petter S. Woll, Sten Eirik W. Jacobsen

Blood (2024) 143 (11): 953–966.

https://doi.org/10.1182/blood.2023022851

Published: 2024

Includes: Supplemental data

Journal Articles

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-138782

Published: 2020

Journal Articles

Identification of an Expanded Immature Cell Population in Human Bone Marrow during Erythroid Responses to ESA Treatment

Isabel Juliana F Hofman, PhD, Teresa Mortera-Blanco, PhD, Sigita Venckute Larsson, Sten Eirik Waelgaard Jacobsen, MD PhD, Petter S Woll, PhD, Marios Dimitriou, PhD, Eva Hellstrom Lindberg, MD PhD

Blood (2019) 134 (Supplement_1): 2993.

https://doi.org/10.1182/blood-2019-130065

Published: 2019

Journal Articles

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Jakob Werner Hansen, MD, Morten Munk Johansen, MD, Maj Karoline Westman, MSc, Leonie Saft, MD PhD, Lene Dissing Sjö, MD PhD, Claus Werenberg Marcher, MD PhD, Mette Skov Holm, MD PhD, Marios Dimitriou, PhD, Mohsen Karimi, PhD, Klas Raaschou-Jensen, MD, Andreas Birkedal Glenthøj, MD PhD, Marianne Tang Severinsen, MD PhD, Eva Hellström-Lindberg, MD PhD, Mette Klarskov Andersen, MD DMSc, Kirsten Grønbæk, Professor, MD DMSc

Blood (2018) 132 (Supplement 1): 794.

https://doi.org/10.1182/blood-2018-99-110767

Published: 2018

Journal Articles

SF3B1 -initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells

Teresa Mortera-Blanco, Marios Dimitriou, Petter S. Woll, Mohsen Karimi, Edda Elvarsdottir, Simona Conte, Magnus Tobiasson, Monika Jansson, Iyadh Douagi, Matahi Moarii, Leonie Saft, Elli Papaemmanuil, Sten Eirik W. Jacobsen, Eva Hellström-Lindberg

Blood (2017) 130 (7): 881–890.

https://doi.org/10.1182/blood-2017-03-776070

Published: 2017

Includes: Supplemental data

Journal Articles

Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia

Yaser Heshmati, Gözde Turköz, Aditya Harisankar, Sten Linnarsson, Marios Dimitriou, Indranil Sinha, Sören Lehmann, Hong Qian, PhD, Julian Walfridsson

Blood (2016) 128 (22): 1648.

https://doi.org/10.1182/blood.V128.22.1648.1648

Published: 2016

Journal Articles

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Christian Scharenberg, MD, Petter S. Woll, PhD, Valentina Giai, MD PhD, Andrea Pellagatti, PhD, Leonie Saft, MD PhD, Marios Dimitriou, Martin Jädersten, Monika Jansson, Iyadh Douagi, PhD, Donna S. Neuberg, ScD, Mohsen Karimi, Katarina Le Blanc, MD, PhD, Jacqueline Boultwood, PhD, Sten Eirik Jacobsen, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2016) 128 (22): 4329.

https://doi.org/10.1182/blood.V128.22.4329.4329

Published: 2016

Journal Articles

Mutations in Histone Modulators Are Associated with Prolonged Survival during Azacitidine Therapy

Magnus Tobiasson, MD, Donal McLornan, MDPhD, Mohsen Karimi, Marios Dimitriou, PhD, Monika Jansson, Asmaa Ben Azenkoud, Martin Jädersten, Greger Lindberg, Hani Abdulkadir, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Johanna Ungerstedt, Associate Professor, Andreas Lennartsson, Karl Ekwall, Ghulam J Mufti, Eva Hellström-Lindberg, MD PhD

Blood (2015) 126 (23): 2839.

https://doi.org/10.1182/blood.V126.23.2839.2839

Published: 2015

Journal Articles

Characterization of the Hematopoietic Stem and Progenitor Cell Hierarchy in Myelodysplastic Syndromes Patients with Monosomy 7 As the Sole Cytogenetic Abnormality

Marios Dimitriou, Teresa Mortera-Blanco, Petter S Woll, PhD, Mohsen Karimi, Helen Doolittle, MD, Sten Eirik W Jacobsen, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2014) 124 (21): 3490.

https://doi.org/10.1182/blood.V124.21.3490.3490

Published: 2014

Journal Articles

Mutations in Histone Modulators and HOXA5 Methylation Levels Affects Survival in Azacitidine Treated MDS Patients

Magnus Tobiasson, MD, Mohsen Karimi, Marios Dimitriou, Ying Qu, MDM.Sc, Andreas Lennartsson, PhD, Hani Abdulkadir Ali, Ashwin Unnikrishnan, PhD, Martin Jadersten, MDPhD, Monika Jansson, Asmaa Ben Azenkoud, John E Pimanda, MD PhD, Karl Ekwall, Prof, Johanna Ungerstedt, MD PhD, Soren Lehmann, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2014) 124 (21): 4613.

https://doi.org/10.1182/blood.V124.21.4613.4613

Published: 2014

Journal Articles

Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation

Simona Conte, Liselotte Vesterlund, PhD, Shintaro Katayama, PhD, Mohsen Karimi, PhD, Elli Papaemmanuil, PhD, Monika Jansson, Teresa Mortera-Blanco, PhD, Marios Dimitriou, PhD, Birgitta Sander, MD, PhD, Tiina Skoog, Peter J. Campbell, PhD, Juha Kere, MD, PhD, Per Unneberg, PhD, Eva Hellström-Lindberg, MD, PhD

Blood (2013) 122 (21): 2408.

https://doi.org/10.1182/blood.V122.21.2408.2408

Published: 2013

Journal Articles

Hierarchical Analysis Of Recurrent Point Mutations In SF3B1 and TET2 In RARS Stem Cells

Teresa Mortera-Blanco, PhD, Marios Dimitriou, PhD, Petter Woll, PhD, Mohsen Karimi, PhD, Elli Papaemmanuil, PhD, Simona Conte, Oni Chowdhuri, Monika Jansson, Peter J. Campbell, PhD, Sten Eirik W Jacobsen, PhD, Eva Hellström-Lindberg, MD, PhD

Blood (2013) 122 (21): 2749.

https://doi.org/10.1182/blood.V122.21.2749.2749

Published: 2013

NARROW

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

Identification of an Expanded Immature Cell Population in Human Bone Marrow during Erythroid Responses to ESA Treatment

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

SF3B1 -initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells

Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Mutations in Histone Modulators Are Associated with Prolonged Survival during Azacitidine Therapy

Characterization of the Hematopoietic Stem and Progenitor Cell Hierarchy in Myelodysplastic Syndromes Patients with Monosomy 7 As the Sole Cytogenetic Abnormality

Mutations in Histone Modulators and HOXA5 Methylation Levels Affects Survival in Azacitidine Treated MDS Patients

Erythropoiesis In SF3B1 Mutated RARS Is Disrupted During Terminal Erythroid Maturation

Hierarchical Analysis Of Recurrent Point Mutations In SF3B1 and TET2 In RARS Stem Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only